Results 61 to 70 of about 2,000 (98)

Vaccine Name Framing, Relationship Status, and Fear: Examining Heterosexual Men's Intention to Vaccinate Against Human Papillomavirus Infection

World Medical &Health Policy, Volume 18, Issue 1, March 2026.
ABSTRACT Against the backdrop of calling for nonfemale‐oriented promotion of vaccination against human papillomavirus (HPV), this study explored three potential names—“HPV Vaccine,” “Cervical Cancer Vaccine,” and “Genital Warts Vaccine”—to promote vaccination against HPV infection among heterosexual men.
Timothy K. F. Fung, Judy Yuen‐man Siu, Ho Man Leung   +2 more
wiley   +1 more source

Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection

Human Vaccines & Immunotherapeutics, 2018
Human papillomavirus (HPV) infection is a frequent cause of malignant and non-malignant disease, in particular among persons with HIV. HPV serotype-specific anti L1 antibodies protect against HPV infection but little is known about prophylactic HPV ...
Maria Zurek Munk-Madsen, Lars Toft, Tina Kube, Rolf Richter, Lars Ostergaard, Ole S. Søgaard, Martin Tolstrup, Andreas M. Kaufmann   +7 more
doaj   +1 more source

EFFICACY OF VACCINE PREVENTION OF HPV-ASSOCIATED DISEASES AND CERVICAL CANCER IN THE MOSCOW REGION

Alʹmanah Kliničeskoj Mediciny, 2016
Data on high prevalence of papilloma virus infection and associated disorders in adults as well as in adolescents are becoming more and more frequently published in the world and domestic literature.
V. I. Krasnopol'skiy, L. S. Logutova, N. V. Zarochentseva, Yu. M. Belaya, G. V. Tamazyan, A. L. Gridchik   +5 more
doaj   +1 more source

Estado actual de la vacuna recombinante contra el virus del papiloma humano State of the art on human papillomavirus vaccine

Acta Médica Costarricense, 2008
La infección por el virus del papiloma humano (VPH) es una enfermedad de transmisión sexual común. Alrededor del mundo millones de personas están infectadas y el resto de la población en general tiene un riesgo de contraer la infección superior al 50 ...
Wendy Chan Acón, Lara Aguilar Morales, Carolina Soley, Adriano Arguedas Mohs   +3 more
doaj  

Estado actual de la vacuna recombinante contra el virus del papiloma humano

Acta Médica Costarricense, 2008
La infección por el virus del papiloma humano (VPH) es una enfermedad de transmisión sexual común. Alrededor del mundo millones de personas están infectadas y el resto de la población en general tiene un riesgo de contraer la infección superior al 50 ...
Wendy Chan Acón, Lara Aguilar Morales, Carolina Soley, Adriano Arguedas Mohs   +3 more
doaj  

Prevalence, Characteristics, and Distribution of Human Papillomavirus According to Age and HIV Status in Women of Eastern Cape Province, South Africa

Viruses
Human papillomavirus (HPV) is a sexually transmitted infection associated with the development of cervical cancer. This study investigated cervical HPV prevalence, characteristics, and distribution according to age and human immunodeficiency virus (HIV ...
Zizipho Z. A. Mbulawa, Sinazo Kondlo, Sinalo Toni, Lindiwe M. Faye, Charles B. Businge   +4 more
doaj   +1 more source

Utilization Evaluation of Human Papilloma Virus Vaccine (GARDASIL®) in Iran; A Cross-Sectional Study. [PDF]

Iran J Pharm Res, 2020
Mohammadpour F, Mansouri A, Hadjibabaie M.   +2 more
europepmc   +1 more source

La retirada de una campaña publicitaria para promoción de la vacuna tetravalente del virus del papiloma humano en España Withdrawal of an advertising campaign to promote the quadrivalent human papilloma virus vaccine in Spain

Gaceta Sanitaria, 2010
La inclusión de la vacuna tetravalente del virus del papiloma humano (VPH) en el Sistema Nacional de Salud aviva el debate sobre Gardasil®, presentada ante la opinión pública como «la vacuna contra el cáncer de cérvix».
Marta Martín-Llaguno, Carlos Álvarez-Dardet   +1 more
doaj  

Adverse events following 9-valent human papillomavirus vaccine (GARDASIL® 9) reported to the Vaccine Adverse Event Reporting System (VAERS), 2015-2024. [PDF]

Hum Vaccin Immunother
Liu Q, Liang G, Song Y.
europepmc   +1 more source

Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy. [PDF]

Hum Vaccin Immunother, 2014
Zhao Q, Potter CS, Carragher B, Lander G, Sworen J, Towne V, Abraham D, Duncan P, Washabaugh MW, Sitrin RD.   +9 more
europepmc   +1 more source